Andon Health Co., Ltd.

Sümbol: 002432.SZ

SHZ

42.43

CNY

Turuhind täna

104.3943
P/E suhe
0.4060
PEG suhe
19.45B
MRK Cap
0.06%
DIV tootlus

Andon Health Co., Ltd. (002432-SZ) Finantsaruanded

Q: Mis on Andon Health Co., Ltd. (002432.SZ) koguvara?

Andon Health Co., Ltd. (002432.SZ) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Andon Health Co., Ltd. (002432.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 2253.652 M, mis on 1.092 % gowth. Kogu perioodi keskmine brutokasum on 1579.143 M, mis on 1.546 %. Keskmine brutokasumi suhtarv on 0.382 %. Ettevõtte eelmise aasta tulemuse puhaskasv on 16.642 %, mis on võrdne 0.847 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Andon Health Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 4.529. Käibevara valdkonnas on 002432.SZ aruandlusvaluutas 13194.977. Märkimisväärne osa neist varadest, täpsemalt 11487.984, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 7.551%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 299.636, kui neid on, aruandlusvaluutas. See näitab erinevust -188.874% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 29.815 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.163%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 19554.218 aruandlusvaluutas. Selle aspekti aastane muutus on 5.807%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 546.059, varude hind on 697.61 ja firmaväärtus 93.56, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 153.65.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007
balance-sheet.row.cash-and-short-term-investments	41841.29	11488	1343.4	1203.1	732	441.7	654.7	791.7	122.1	117.9	338.7	376.8	440.3	545.9	19.4	31.6	84.5
balance-sheet.row.short-term-investments	26244.4	6044	447.8	289.4	400.8	3.3	0	37	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	1332.68	546.1	839.9	186.5	131.2	197.8	136.6	207.5	96.1	139.5	128.4	115.4	119.3	93.1	86.8	46.7	29.6
balance-sheet.row.inventory	1731.43	697.6	627.8	281.3	196.7	239.3	203.8	234.2	270.3	272.7	204.4	130.7	134.2	78.3	44.8	58.2	39
balance-sheet.row.other-current-assets	1137.01	463.3	47.7	4.3	3.7	13	144.6	259.9	6.9	166.7	3.6	-2.8	-17.6	-10.4	-12.6	-8.5	-6.4
balance-sheet.row.total-current-assets	46042.41	13195	2858.9	1675.3	1063.7	891.7	1139.7	1493.2	495.4	696.7	675	620.1	676.1	706.9	138.5	128	146.7
balance-sheet.row.property-plant-equipment-net	1396.13	319.7	231.7	187.1	208.9	223.1	208.6	218.1	218.8	193.2	180.2	143.6	112.5	74.2	62.9	41.3	4.2
balance-sheet.row.goodwill	190.66	93.6	218.9	243.3	359.4	437.3	522.6	489.4	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	561.75	153.6	171.8	154.8	169.9	178	153	133.9	81.3	79	70.1	51.6	42.6	37.9	34.9	35.6	0
balance-sheet.row.goodwill-and-intangible-assets	752.41	247.2	390.7	398.1	529.3	615.3	675.6	623.3	81.3	79	70.1	51.6	42.6	37.9	34.9	35.6	0
balance-sheet.row.long-term-investments	7299.49	299.6	-337.1	-170.8	-358.8	75.5	56	-31.4	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	297.35	52.5	72.7	27	20.7	14.5	15.8	14.6	9.8	7.3	8.5	2.2	3.4	0.3	0.2	0.1	0
balance-sheet.row.other-non-current-assets	32424.67	7616.6	713.4	342	476.4	88.2	2.4	38.4	14.5	26.2	0.4	1	1.9	2.9	1.5	0.4	0.6
balance-sheet.row.total-non-current-assets	42170.04	8535.7	1071.5	783.3	876.6	1016.5	958.4	863	324.4	305.7	259.1	198.4	160.4	115.3	99.4	77.4	4.8
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	88212.45	21730.6	3930.3	2458.6	1940.3	1908.2	2098.1	2356.2	819.9	1002.4	934.2	818.5	836.5	822.2	237.8	205.4	151.5
balance-sheet.row.account-payables	600.42	312	191	139.4	78.9	77.8	51.9	32.4	33	78.8	55.3	38.5	41.7	27.7	42.5	55.2	23.8
balance-sheet.row.short-term-debt	1744.82	287.9	345.4	243.8	1.2	150	359.4	141.3	49.3	102.7	96.6	0	0	0	0	0	0
balance-sheet.row.tax-payables	134.02	41.3	130.4	27	7	14	6.3	5	1.8	1.9	8.2	0.2	3.8	2.1	4	0.8	1.4
balance-sheet.row.long-term-debt-total	290.32	29.8	34.4	128.2	197.5	72.5	0	306.5	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	66.33	18.2	21.8	8.7	2.1	2	6.6	5.6	5.6	3.1	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	3609.92	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	229.18	111.2	0.7	1.4	22.1	61.9	14.4	8.9	9	8	11	22.2	19.3	14.6	17	10.8	8.4
balance-sheet.row.total-non-current-liabilities	3966.57	907.2	56.2	136.9	201.5	78.2	13	319.6	5.6	3.1	0	0	0	0	0	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	90.19	29.8	34.4	47.7	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	6951.68	1705.9	1094.1	636.1	341.7	381.9	729.1	814.6	210.9	243.7	186.4	60.7	60.9	42.3	59.5	66.1	32.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1940.71	484.5	481.4	432.8	432.8	432.8	432.8	432.8	372	372	372	248	248	124	93	93	93
balance-sheet.row.retained-earnings	66130.28	16550.3	977.9	134.4	-104.2	-209.4	-222.1	-73.6	-88.1	70.1	59.9	72.1	90.6	96.2	74.8	39.8	22.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	8609.55	982.8	18.5	18.7	35	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	2290.82	1536.6	1394.8	1298.9	1298.9	1319.3	1158.4	1182.4	325	316.7	315.8	437.6	436.9	559.7	10.6	6.5	3.4
balance-sheet.row.total-stockholders-equity	78971.36	19554.2	2872.6	1884.8	1662.5	1542.7	1369.1	1541.6	608.9	758.8	747.7	757.7	775.6	780	178.4	139.3	119.3
balance-sheet.row.total-liabilities-and-stockholders-equity	88212.45	21730.6	3930.3	2458.6	1940.3	1908.2	2098.1	2356.2	819.9	1002.4	934.2	818.5	836.5	822.2	237.8	205.4	151.5
balance-sheet.row.minority-interest	2289.42	470.5	-36.4	-62.3	-64	-16.4	-0.1	0	0	0	0.1	0	0	0	0	0	0
balance-sheet.row.total-equity	81260.78	20024.7	2836.2	1822.5	1598.5	1526.3	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	88212.45	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	33543.89	6343.7	110.7	118.6	42	78.8	56	5.6	13.8	25.2	0	0	0	0	0	0	0
balance-sheet.row.total-debt	2035.14	317.8	379.8	372	198.8	222.5	359.4	447.7	49.3	102.7	96.6	0	0	0	0	0	0
balance-sheet.row.net-debt	-13561.75	-5126.2	-515.7	-541.7	-132.5	-215.8	-295.3	-306.9	-72.8	-15.2	-242.1	-376.8	-440.3	-545.9	-19.4	-31.6	-84.5

Rahavoogude aruanne

Andon Health Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 79.882 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 139.14, mis tähistab 0.656 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -12943376393.150. See on 35.233 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 106.05, 6.82, -318.43, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -322.03 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 364.64, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007
cash-flows.row.net-income	190.62	16484.1	934.4	236.8	27.1	-2.9	-165.9	14.5	-150.8	8.4	-8.5	7	20.8	23.7	39	31.3	43.9
cash-flows.row.depreciation-and-amortization	73.1	106	89.4	62.8	59.5	55	46.8	35	24.7	20.8	10.7	7.5	5.6	4.1	3.1	1.1	0.8
cash-flows.row.deferred-income-tax	-1204.22	882.4	-30.4	-8.1	-8.1	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	321.63	164.7	9.2	2	8.1	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	132.38	818.2	-719.2	-82.6	26.7	-136.6	45.5	65.9	-27.3	-14.6	-85	-12	-60.2	-64.1	-0.8	-29.8	-3.7
cash-flows.row.account-receivables	353.29	353.3	-718.6	-68.8	-16.5	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-220.92	-220.9	-332.1	-87.1	17.1	-43	27.4	49.3	2.3	-68.3	-73.7	3.5	-55.9	-33.5	13.4	-19.2	-21.1
cash-flows.row.account-payables	-185.32	-196.6	361.9	81.4	34.3	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	185.32	882.4	-30.4	-8.1	-8.1	-93.6	18.1	16.6	-29.7	53.7	-11.4	-15.4	-4.4	-30.6	-14.1	-10.6	17.4
cash-flows.row.other-non-cash-items	1516.93	-233.7	9.8	250.7	-157	-19.7	-18.3	-151.9	23.9	-83.5	8.4	2.7	2.1	10.2	1.3	-0.1	-3.9
cash-flows.row.net-cash-provided-by-operating-activities	873.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-249.04	-211.9	-70.4	-53.8	-60.7	-179.7	-56.5	-69.6	-31.6	-58.5	-60.6	-43.7	-48.5	-17.9	-54.4	-40	-2.3
cash-flows.row.acquisitions-net	0.52	0.5	0.1	-18.8	42.5	-16.9	23.7	-250.8	34.3	39.8	0	0	0	0	0	0	2.3
cash-flows.row.purchases-of-investments	-17622.13	-13981.8	-618.3	-1135.2	-663.7	-33.3	-254	-250	-30	-153	0	0	0	0	0	-1.1	-4.2
cash-flows.row.sales-maturities-of-investments	8006.33	1243.1	326.5	1114.4	645.5	6.4	515.3	69.7	188.5	58.8	0	0	0	0	0	1.6	8.2
cash-flows.row.other-investing-activites	-7.3	6.8	5	-15	3.8	13.3	-46.4	-69.6	0	-58.5	0	0	0	0	0	-2	-2.3
cash-flows.row.net-cash-used-for-investing-activites	-9871.62	-12943.4	-357.2	-108.4	-32.7	-210.2	182.1	-570.3	161.2	-171.4	-60.6	-43.7	-48.5	-17.9	-54.4	-41.5	1.7
cash-flows.row.debt-repayment	-199.58	-318.4	-253.6	-9.5	-150.7	-442.4	-146.5	-71	-154.8	-146.6	-36	0	0	0	-6	-10.9	0
cash-flows.row.common-stock-issued	142.9	139.1	31.6	-0.8	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-142.9	-139.1	-199.8	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-3.94	-322	-36.7	-6.7	-8.7	-6.3	-11	-4.5	-9.8	-3.7	-0.7	-24.8	-24.8	0	-0.1	-11.1	0
cash-flows.row.other-financing-activites	541.85	364.6	523.5	171.9	-20.5	345.3	69.2	1305.9	147.3	149.8	133.9	0.1	0	570.8	5.9	7.6	15.4
cash-flows.row.net-cash-used-provided-by-financing-activities	-839.15	-275.8	65	155.7	-179.9	-103.4	-88.2	1230.4	-17.2	-0.5	97.1	-24.7	-24.8	570.8	-0.2	-14.4	15.4
cash-flows.row.effect-of-forex-changes-on-cash	-395.19	15.8	-14.2	-28	0.7	8.5	-9.3	4.7	4.6	0	-0.2	-0.4	-0.5	-0.3	-0.5	0.5	0
cash-flows.row.net-change-in-cash	-8833.49	5018.3	-13.4	480.9	-255.5	-409.3	-7.2	628.2	19.2	-240.8	-38.1	-63.5	-105.6	526.6	-12.4	-52.9	54.2
cash-flows.row.cash-at-end-of-period	15646.56	5559.1	540.8	554.2	73.3	328.7	738	745.3	117.1	97.9	338.7	376.8	440.3	545.9	19.3	31.6	84.5
cash-flows.row.cash-at-beginning-of-period	24480.06	540.8	554.2	73.3	328.7	738	745.3	117.1	97.9	338.7	376.8	440.3	545.9	19.3	31.6	84.5	30.3
cash-flows.row.operating-cash-flow	873.5	18221.7	293.1	461.6	-43.7	-104.2	-91.9	-36.5	-129.5	-68.9	-74.5	5.2	-31.7	-26	42.7	2.5	37.1
cash-flows.row.capital-expenditure	-249.04	-211.9	-70.4	-53.8	-60.7	-179.7	-56.5	-69.6	-31.6	-58.5	-60.6	-43.7	-48.5	-17.9	-54.4	-40	-2.3
cash-flows.row.free-cash-flow	624.46	18009.8	222.7	407.9	-104.4	-283.9	-148.4	-106.1	-161.1	-127.4	-135.1	-38.5	-80.3	-43.9	-11.7	-37.4	34.8

Kasumiaruande rida

Andon Health Co., Ltd. tulud muutusid võrreldes eelmise perioodiga 9.978%. 002432.SZ brutokasum on teatatud 20948.17. Ettevõtte tegevuskulud on 2271.96, mille muutus võrreldes eelmise aastaga on 305.866%. Kulud amortisatsioonikulud on 106.05, mis on 5.975% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 2271.96, mis näitab 305.866% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 17.265% kasvu võrreldes eelmise aastaga. Tegevustulu on 18311.87, mis näitab 17.265% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on 16.642%. Eelmise aasta puhaskasum oli 16030.17.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007
income-statement-row.row.total-revenue	4471.03	26315.4	2397.1	2008.4	706.3	563.9	597.9	420.1	397.9	425.5	407.6	356.1	354.1	298.7	313.2	279.5	216.9
income-statement-row.row.cost-of-revenue	1607.24	5367.2	875.5	877.5	502.9	394.9	414.9	284.4	295.6	292.6	274.7	237.3	235.9	196.9	207.7	195	139
income-statement-row.row.gross-profit	2863.8	20948.2	1521.5	1130.9	203.3	168.9	183	135.8	102.3	132.8	132.9	118.8	118.2	101.8	105.5	84.5	77.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	307.16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	360.34	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	606.23	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	450.77	430.9	151.1	147.3	96	87	6.9	4.4	0.1	2.8	2.8	0.7	0.4	4	1	-0.4	0.4
income-statement-row.row.operating-expenses	1735.79	2272	559.8	659.9	352.8	282.8	349.6	268.7	232.2	215.8	148.5	126.5	108.3	83.1	59.4	48.9	34
income-statement-row.row.cost-and-expenses	3343.03	7639.2	1435.3	1537.4	855.7	677.8	764.5	553	527.8	508.4	423.2	363.8	344.3	280	267.1	243.9	173.1
income-statement-row.row.interest-income	113.23	180.6	16.8	9.6	9.5	14.8	6.9	11.2	0.9	7.4	16.7	16.8	17.8	7.6	0.3	1.1	0
income-statement-row.row.interest-expense	14.62	4.8	13.3	7	8.3	6.9	11.4	4.8	1.8	4.1	1.2	0	0	0.4	0.3	0.1	0.7
income-statement-row.row.selling-and-marketing-expenses	606.23	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-27.37	-54	-2.9	-538	167.9	109	9.1	145.5	-23.1	92.9	7.6	14.5	14.5	8.7	-0.8	-0.1	3.6
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	450.77	430.9	151.1	147.3	96	87	6.9	4.4	0.1	2.8	2.8	0.7	0.4	4	1	-0.4	0.4
income-statement-row.row.total-operating-expenses	-27.37	-54	-2.9	-538	167.9	109	9.1	145.5	-23.1	92.9	7.6	14.5	14.5	8.7	-0.8	-0.1	3.6
income-statement-row.row.interest-expense	14.62	4.8	13.3	7	8.3	6.9	11.4	4.8	1.8	4.1	1.2	0	0	0.4	0.3	0.1	0.7
income-statement-row.row.depreciation-and-amortization	719.39	723.8	103.8	62.8	66	55	46.8	35	24.7	20.8	10.7	7.5	5.6	4.1	3.1	1.1	0.8
income-statement-row.row.ebitda-caps	1730.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1010.9	18311.9	1002.5	777.8	-149.5	-91.9	-171.3	8.2	-153.2	20.3	-10.7	6.1	24	23.4	44.2	35.9	47.1
income-statement-row.row.income-before-tax	983.53	18257.9	999.6	239.8	18.4	-4.9	-157.5	12.6	-153.1	9.9	-8	6.7	24.4	27.4	45.2	35.6	47.5
income-statement-row.row.income-tax-expense	706.46	1773.8	65.2	2.9	-8.7	-2.1	8.4	-1.9	-2.3	1.5	1.4	-0.2	3.6	3.7	6.2	4.3	3.6
income-statement-row.row.net-income	190.62	16030.2	908.6	242.3	27.1	12.7	-165.9	14.5	-150.8	10.2	-9.2	7	20.8	23.7	39	31.3	43.9